• No results found

cancer/testis antigen

Cancer-testis antigen MAGE-C2 binds Rbx1 and inhibits ubiquitin ligase-mediated turnover of cyclin E

Cancer-testis antigen MAGE-C2 binds Rbx1 and inhibits ubiquitin ligase-mediated turnover of cyclin E

... Cancer-testis antigen MAGE-C2 is normally expressed in testis but aberrantly expressed in various kinds of tumors. Its functions in tumor cells are mostly unknown. Here, we show that MAGE-C2 ...

12

Cancer testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma

Cancer testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma

... a cancer- testis antigen, SLLP1 RNA was also present in normal testis tissue but, importantly, it was absent from the whole BM of 11 healthy donors analyzed (Figure 1a) thus indicating a ...

12

Cancer testis antigen and immunotherapy

Cancer testis antigen and immunotherapy

... a cancer vaccine is dependent on the ability of a patient to mount a primary or memory immune response against cancer antigens used in the ...of cancer vaccine studies have focused on patients with ...

9

Molecular Expression Analysis of Restrictive Receptor for Interleukin 13, a Brain Tumor-associated Cancer/Testis Antigen

Molecular Expression Analysis of Restrictive Receptor for Interleukin 13, a Brain Tumor-associated Cancer/Testis Antigen

... (Fig. 4, panels I, II, and IV). The presence of the transcripts within the CNS was most evident, as was the case for IL13R , in medulla, spinal cord, substantia nigra and thalamus (blot # 7775-1, dots 2-G, 3-E, 3-A, 3-C ...

10

Original Article Expression status and prognostic value of cancer/testis antigen OY-TES-1 in glioma

Original Article Expression status and prognostic value of cancer/testis antigen OY-TES-1 in glioma

... Our result suggested that preparing OY-TES-1 antigen-related tumor vaccine might enhance therapy effect of glioma in future. However, from the view point of our research or pertinent published literatures, this ...

10

Prevalence of plasma autoantibody against cancer testis antigen NY ESO 1 in HTLV 1 infected individuals with different clinical status

Prevalence of plasma autoantibody against cancer testis antigen NY ESO 1 in HTLV 1 infected individuals with different clinical status

... The data directly demonstrate the presence of autoreac- tive antibodies against CT antigen NY-ESO-1 in the peripheral blood of HTLV-1-infected individuals, irre- spective of clinical status. Since NY-ESO-1 is one ...

6

Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy

Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy

... in antigen processing, such as downregulation of Transporter Associated with Antigen Processing 1 (TAP1) expression, have been reported in a variety of different cancer types and have been shown to ...

17

Establishment of cancer/testis antigen profiling based on clinicopathological characteristics in resected pathological stage III non-small cell lung cancer

Establishment of cancer/testis antigen profiling based on clinicopathological characteristics in resected pathological stage III non-small cell lung cancer

... EGFR tyrosine kinase inhibitors were demonstrated to greatly improve the disease-free survival of resected stage II–IIIA EGFR-mutant lung cancer patients. In our study, we also evalu- ated the association between ...

16

Original Article Down-regulation of cancer/testis antigen OY-TES-1 attenuates malignant behaviors of hepatocellular carcinoma cells in vitro

Original Article Down-regulation of cancer/testis antigen OY-TES-1 attenuates malignant behaviors of hepatocellular carcinoma cells in vitro

... liver cancer cell lines available to us (Figure 1A), we could not perform the functional an- alysis of OY-TES-1 gene by transfecting it into OY-TES-1 negative liver cancer cell ...

12

Original Article Cancer testis antigen OY-TES-1 expression and serum immunogenicity in colorectal cancer: its relationship to clinicopathological parameters

Original Article Cancer testis antigen OY-TES-1 expression and serum immunogenicity in colorectal cancer: its relationship to clinicopathological parameters

... OY-TES-1 coding sequence from nucleotides 28 to 1723 was amplified from human testis cDNA by PCR with Primers (sense: 5’-GCGGGCGGAT- CTTCTCCGGCCATG-3’; antisense: 5’-ACGGGA- TCCTTATCAGTTGGGCTGGGGTGT-3’). PCR prod- ...

11

Down-regulation of the cancer/testis antigen 45 (CT45) is associated with altered tumor cell morphology, adhesion and migration

Down-regulation of the cancer/testis antigen 45 (CT45) is associated with altered tumor cell morphology, adhesion and migration

... CT-X antigen SAGE (CT14) and the D-E-A-D box containing protein DDX26 ...ovarian cancer and multiple myeloma, CT45 is expressed in a larger number of cases ...

12

CETN1 is a cancer testis antigen with expression in prostate and pancreatic cancers

CETN1 is a cancer testis antigen with expression in prostate and pancreatic cancers

... the cancer cells, which generally come from epithelial cells, to become more motile and aggres- ...successful cancer treatment, since without metastasis, most solid organ cancers would not be fatal ...

7

Review Article Colon adenocarcinoma prognosis by BORIS a cancer-testis antigen

Review Article Colon adenocarcinoma prognosis by BORIS a cancer-testis antigen

... Ovarian Cancer Study Group, Williams RT, Flemming C, Lambrechts D, Despierre E, Lambrechts S, Vergote I, Kar- lan B, Lester J, Orsulic S, Walsh C, Fasching P, Beckmann MW, Ekici AB, Hein A, Matsuo K, Hosono S, ...

6

Cancer/Testis Antigens and Colorectal Cancer

Cancer/Testis Antigens and Colorectal Cancer

... The cancer/testis antigen (CTA) genes have attracted a great deal of interest; particularly in the field of oncology and tumour immunology ...termed testis/brain-restricted and ...

10

Complete Remission Following Decitabine/Dendritic Cell Vaccine for Relapsed Neuroblastoma

Complete Remission Following Decitabine/Dendritic Cell Vaccine for Relapsed Neuroblastoma

... upregulate cancer testis antigen expression, followed by a dendritic cell vaccine targeting the cancer testis antigens MAGE- A1, MAGE-A3, and ...tumor antigen expression followed ...

8

Cancer/testis antigens (CTAs) expression in resected lung cancer

Cancer/testis antigens (CTAs) expression in resected lung cancer

... Results: High expression of MAGEA1 (16.7% vs 65.0%, P=0.004), MAGEA10 (61.1% vs 95.0%, P=0.016), MAGEB2 (55.6% vs 95.0%, P=0.007), and KK-LC-1 (16.7% vs 55.0%, P=0.020) was closely correlated with lymph node metastasis ...

9

MAGE-A1 in lung adenocarcinoma as a promising target of chimeric antigen receptor T cells

MAGE-A1 in lung adenocarcinoma as a promising target of chimeric antigen receptor T cells

... tumor antigen that is physiologically expressed in the germ cells of the testes as well as in a variety of malignant tumors but not in normal tissues ...for cancer immunotherapy [17, ...novel cancer ...

18

Association of serum follistatin levels with histological types and progression of tumor in human lung cancer

Association of serum follistatin levels with histological types and progression of tumor in human lung cancer

... gonadal cancer, gastric cancer, hepatocellular carcinoma, basal cell carci- noma, and melanoma ...lung cancer patients with different histological types, TNM staging, tumor progression, and ...

8

Inducible expression of cancer-testis antigens in human prostate cancer

Inducible expression of cancer-testis antigens in human prostate cancer

... To evaluate the translational relevance of these findings, we developed a novel approach to test EMAs in human cancer with an ex vivo tissue culture with human PC specimens. Similar drug cultures were used by ...

16

Diagnostic value of serum cancer antigen 125 in ovarian cancer patients

Diagnostic value of serum cancer antigen 125 in ovarian cancer patients

... ovarian cancer, CA 125 levels were found to correlate with tumor burden in 93% of cases (Drescher, ...ovarian cancer in the general population and the risk of a false-positive ...ovarian cancer was ...

7

Show all 10000 documents...

Related subjects